Therapeutics News

Results of a literature review published in the Journal of the American Academy of Dermatology showed a complex correlation between chronic inflammatory skin disease, such as atopic dermatitis and psoriasis, and sleep loss.

The FDA denied approval to Verrica Pharmaceuticals’ molluscum contagiosum treatment VP-102, the company announced in a press release.

The use of glycopyrronium cloth without occlusion for 30 minutes had the best results in treating palmar hyperhidrosis, according to results of a virtually conducted study.

Aristea Therapeutics has dosed the first patient in a phase 2b trial of its palmoplantar pustulosis candidate RIST4721, the company announced in a press release.

Patients with chronic spontaneous urticaria demonstrated improved outcomes related to idiopathic angioedema after taking omalizumab, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

While the level of evidence was generally low, spironolactone was not associated with statistically significant increased risk for a number of cancers, according to findings from a retrospective meta-analysis.

As the use of cannabis products becomes more frequent for dermatologic conditions, clinicians should be aware of barriers and stay up to date with both the science and legal sides of its use, according to a study.

Implicit racial bias could play a part in antibiotics prescribed for skin and soft tissue infections, according to a research letter published in JAMA Network Open.

Superficial radiotherapy yielded complete remission in 90% of treated areas in a small cohort of individuals with Hailey-Hailey disease, according to recent findings.

The FDA approved Rinvoq, a selective JAK inhibitor, for the treatment of moderate to severe atopic dermatitis among patients aged 12 years and older, according to a press release.